Pharmaceutical Product Research and Development | Pharmaceutical Product Development

HOME

Tuesday, May 13, 2008

SEARCH

BIO AUSTRALIA

BIO CHINA

BIO INDIA

BIO INDONESIA

BIO JAPAN

BIO KOREA

BIO MALAYSIA

BIO NEW ZEALAND

BIO PHILIPPINES

BIO SINGAPORE

BIO TAIWAN

BIO THAILAND

NEW DEVELOPMENTS

	Merck initiates Phase II trial of Atacicept in RMS patients

	Merck KGaA announced that its Merck Serono division and ZymoGenetics, are initiating a Phase II clinical trial to evaluate the safety and efficacy of atacicept in patients with relapsing multiple sclerosis (RMS)

	Advinus achieves milestones in Merck collaboration

	Advinus Therapeutics, engaged in Pharmaceutical R&D headquartered in Bangalore, announced that it has achieved two more milestones, under the drug discovery and development collaboration between Advinus Therapeutics and Merck & Co

TODAY'S NEWS

	Helicon group secures China rights For Collatamp G

	Premier Biosoft releases SimGlycan 2.51 with Glycopeptide Analysis

	Starpharma reports positive VivaGel clinical study results

	IBN scientists develop Extreme Lab-on-a-chip

	FDA approves new formulation of coagulation therapy

	MakroCare opens Europe office in Germany

	Advertisement

	Digital Mag
Updated Fortnightly Issue: April 30, 2008 Current Issue View / Download
	Top Story
China steps up the pace: India and China are racing to become lucrative pharmaceutical markets for global players

R & D

Merck initiates Phase II trial of Atacicept in RMS patients

Merck KGaA announced that its Merck Serono division and ZymoGenetics, are initiating a Phase II clinical trial to evaluate the safety and efficacy of atacicept in patients with relapsing multiple sclerosis (RMS)

Advinus achieves milestones in Merck collaboration

Advinus Therapeutics, engaged in Pharmaceutical R&D headquartered in Bangalore, announced that it has achieved two more milestones, under the drug discovery and development collaboration between Advinus Therapeutics and Merck & Co

GlaxoSmithKline, Regulus announce microRNA Therapeutics collaboration

GlaxoSmithKline and Regulus Therapeutics announced a worldwide strategic alliance to discover, develop and market novel microRNA-targeted therapeutics to treat inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease

Starpharma's SPL7013 indicates potential application for arthritis

Melbourne-based Starpharma has filed a patent application for the use of SPL7013, the active ingredient in VivaGel, to inhibit hyaluronidase activity in the treatment or prevention of a multiple diseases

ChemGenex to initiate NDA submission for Omacetaxine

ChemGenex, a pharmaceutical development company based in Melbourne confirmed its intent to initiate a rolling New Drug Application submission in support of omacetaxine mepesuccinate

TaiGen announces positive data from Phase II study of Nemonoxacin

TaiGen Biotechnology, a leading development stage pharmaceutical company based in Taiwan announced that the nemonoxacin phase II top-line data in community-acquired pneumonia met the primary endpoint of non-inferiority versus levofloxacin

Vertex claims CF drug successful

Researchers from Vertex Pharmaceuticals have claimed success in their phase 2a clinical trial of drug to treat cystic fibrosis (CF)

UQs brain disorder research lab to target motor neuron disease

The research lab has been entirely funded by a $6 million grant from Peter Goodenough, a businessman who succumbed to motor neuron disease (MND)

ChemGenex launches phase 2 study evaluating Omacetaxine in AML patients

ChemGenex Pharmaceuticals, a pharmaceutical development company dedicated to improving the lives of patients, has launched a new phase 2 study evaluating the use of omacetaxine mepesuccinate in refractory or relapsed acute myeloid leukemia patients

Researchers adapt drug dosing to body size

University of Queensland researchers are leading the charge in adapting drug dosing to a society that is changing shape


	Advertisement

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Contact Us | Privacy Statement



		CyberMedia Network Websites [Voice&Data] [PCQuest] [CIOL] [Dataquest] [Living Digital] [IDC India] [CIOL Shop] [DQ Channels] [The DQweek] [CyberMedia Dice] [CyberMedia Events] [CyberMedia Digital] [Cyber Astro] [CyberMedia India] [Global Services] [BioSpectrum]



		Copyrights are reserved for BioSpectrum ; Designed by : Altered Black